Dr Reddys launches Bortezomib for Injection in US - Video
|
Overview
Drugmaker, Dr Reddy's Laboratories Ltd., has announced the launch of Bortezomib for Injection 3.5 mg, the generic equivalent of Velcade (bortezomib) Injection, in the U.S. market approved by the U.S. Food and Drug Administration (USFDA).
Bortezomib for injection is a proteasome inhibitor indicated for:
· treatment of adult patients with multiple myeloma
· treatment of adult patients with mantle cell lymphoma
For more details, check out the full story on the link below:
Dr Reddy's Labs Unveils Bortezomib For Injection In US
Speakers
Rahul Verma joined Medical Dialogues in the year 2022 and is currently working as a Video editor & Medical correspondent. He has completed his graduation in Bachelors of Arts (BA) from IGNOU. He likes to keep himself and the world updated on the occurring in the medical field. He can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751
